Emerald Health Therapeutics, Inc. EMHTF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

28/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Emerald Health Therapeutics, Inc. (EMHTF) reported total assets of $40.89M and total liabilities of $7.24M for fiscal year 2021, resulting in total equity of $33.65M.

The company held $18.51M in cash and short-term investments. Total debt stood at $3.68M, with net debt of $-14.83M. The Debt-to-Equity (D/E) ratio was 0.11 (conservative).

Current ratio is 3.08, indicating strong short-term liquidity. Interest coverage is -55x (weak).

Criteria supported by this page:

HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
MOAT (15/100) — Total assets $40.89M and equity $33.65M support the company's competitive scale

Overall SharesGrow Score: 28/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

28/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✗

FUTURE

20/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

15/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Emerald Health Therapeutics, Inc. Balance Sheet History

Metric	FY2021	FY2020	FY2019	FY2018
Total Assets	$40.89M	$98.27M	$156.62M	$206.96M
Total Liabilities	$7.24M	$26.17M	$53.45M	$36.46M
Total Debt	$3.68M	$4.16M	$27.77M	$2.5M
Cash & Investments	$18.51M	$26M	$2.53M	$36.04M
Total Stockholders Equity	$33.65M	$73.46M	$103.93M	$170.5M